PHA Find a Doctor Directory Profile Display

Is this your listing?

Update your profile (for current PHCR members only)
Lapsed members: Renew membership

PHA's Scientific Leadership Council identified several questions to assist patients in identifying a PH specialist for their care. The answers below were provided by doctors to help patients assess their qualifications. PHA has not confirmed the validity of this information and is relying on answers provided by physicians who wish to be listed in our Find a Doctor Directory. The following information is publicly available. If a field is blank, the member may have opted to make the corresponding information private.

If you have additional questions regarding the use of this directory, please contact

View our Privacy Policy for information regarding the use of personal information. Any use of the information contained in this or any profile for direct or indirect soliciting, profit, or mass emailing is strictly prohibited. The Pulmonary Hypertension Association reserves the right to restrict or deny access to this site for misuse.


Contact Information:

Name: Farhan Abdul Rauf, PhD, MD, MPH
Institution/Practice: Our Own Public Health Institute (OOPHI)
Position/Title: Associate Director of Programs & Services
Academic Appointment (if any):
Business Address: Saima Classic, Flat G411,
Gulshan-e-Iqbal, Block 10A,
Main Rashid Minhas Road
Business Phone:
Business Email:

Are you certified to practice in your country in any of the following?

Internal Medicine:   Yes      Expires: 2022
Pulmonary Medicine:   Yes      Expires: 2022
Cardiology:   No      Expires:
Rheumatology:   No      Expires:
Pediatrics:   Yes      Expires: 2022
Pediatric Cardiology:   No      Expires:
Pediatric Critical Care:   Yes      Expires: 2022
Pediatric Pulmonary:   No      Expires:
Pediatric Rheumatology:   No      Expires:
I treat patients with:   WHO Group 5 - Metabolic Disorders; WHO Group 2 - Valvular Disease; WHO Group 5 - Hematologic Disorders; WHO Group 3 - COPD; WHO Group 3 - Developmental Abnormalities; WHO Group 3 - Alveolar Hypoventilation Disorders; WHO Group 3 - Chronic Exposure to High Altitudes; WHO Group 2 - Diastolic Dysfunction; WHO Group 5 - Systemic Disorders; WHO Group 3 - Sleep-disordered Breathing; WHO Group 1 - Portal Hypertension; WHO Group 2 - Systolic Dysfunction; WHO Group 1 - Drug and Toxin Induced

Practice Information

Are you currently accepting new patients? Yes
What year did you begin caring for PH patients? 2003
Percentage of practice devoted to PH patients: 70%
How many PH patients do you currently care for? 11-25
Do you have one or more nurses dedicated to PH? Yes
Do you require cardiac catheterization? No   If yes:
Do you provide access to all PAH therapies? Yes   If yes: Through referral to another physician or PH Center
Do you provide access to clinical trials? No   If yes:
Do you refer patients for heart/lung transplant? Yes   If yes: Through referral to another physician or PH Center
Do you refer patients for thromboendarterectomy? Yes   If yes: Through referral to another physician or PH Center
Number of patients on parenteral therapy: 0
Does your hospital have PH protocols and training? Yes
Does your hospital have PAH meds in stock? Yes
Is the ER familiar with PAH and its treatments? Yes
Medical conferences attended in the past year:
Have you attended PHA's International Conference? No

FacebookGoogle +TwitterLinkedInPinterestInstagramYouTubeBloggerFeedsPHAware Download our App

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2015 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.